학술논문

P17.02 Durvalumab After chemoRadioTherapy (DART) for NSCLC Patients – a Phase II Translational and Biomarker Study
Document Type
Abstract
Source
In Journal of Thoracic Oncology March 2021 16(3) Supplement:S351-S352
Subject
Language
ISSN
1556-0864